Our three guests were: Svetlana Mojsov, who is a pioneer in the study of this crucial hormone and whose research has been instrumental in the development of GLP-1 receptor agonists Richard DiMarchi, whose academic expertise and work within the pharmaceutical industry has played a pivotal role in advancing both the scientific understanding and clinical application of GLP-1 therapies Stefan Trapp, who leads a research group that investigates the physiological functions of GLP-1 and its potential as a therapeutic target for metabolic diseases Speakers Svetlana Mojsov Svetlana Mojsov is a research associate professor at Rockefeller University, US
Mild side effects can include: Stomach discomfort or bloating Nausea or upset stomach Headache or fatigue Allergic skin reactions (itching or rash) These usually resolve after discontinuation or dose adjustment
Semaglutide is not known to increase the risk of side effects specifically related to oral contraceptives
But whats unique about GLP-1 use is that these drugs can potentially simulate rapid weight loss, which could worsen muscle loss compared to more gradual weight loss, Pinto says
Subsequently, TFAM translocates to the mitochondrial matrix, where it stimulates mtDNA replication and mitochondrial gene expression, but also act as protection against mtDNA damage and oxidation (Kang et al